Page last updated: 2024-10-30

kynurenic acid and Experimental High Pressure Neurological Syndrome

kynurenic acid has been researched along with Experimental High Pressure Neurological Syndrome in 2 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Research Excerpts

ExcerptRelevanceReference
"4."1.29Possible NMDA antagonist properties of drugs that affect high pressure neurological syndrome. ( Bowser-Riley, F; Davies, SN; Shuker, MA, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shuker, MA1
Bowser-Riley, F1
Davies, SN1
Wardley-Smith, B1
Halsey, MJ1
Hawley, D1
Joseph, MH1

Other Studies

2 other studies available for kynurenic acid and Experimental High Pressure Neurological Syndrome

ArticleYear
Possible NMDA antagonist properties of drugs that affect high pressure neurological syndrome.
    British journal of pharmacology, 1994, Volume: 111, Issue:3

    Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Alkaloids; Animals; Benzimidazoles; High Pressure Ne

1994
The effects of kynurenic acid, quinolinic acid and other metabolites of tryptophan on the development of the high pressure neurological syndrome in the rat.
    Neuropharmacology, 1989, Volume: 28, Issue:1

    Topics: Animals; Central Nervous System Diseases; High Pressure Neurological Syndrome; Kynurenic Acid; Male;

1989